Brief: BB Biotech Q4 Net Loss At CHF 546 Mln
Jan 21 (Reuters) - BB BIOTECH AG BION.S :
* Q4 NET LOSS OF CHF 546 MN
* 2021 WAS A DIFFICULT YEAR FOR BIOTECH EQUITY MARKETS -
INCREASED
DIVIDEND OF CHF 3.85 PROPOSED
* NET LOSS FOR BB BIOTECH IN 2021 WAS CHF 405 MN
Further company coverage: BION.S
(Gdansk Newsroom)
((Gdansk.Newsroom@thomsonreuters.com;))
Recent news on Bb Biotech AG
See all newsBrief: BB Biotech Reports Net Profit Of CHF 451 Mln In Q2 2026
Switzerland's BB Biotech Q1 net loss narrows amid portfolio rotation
Brief: BB Biotech Reports Q1 Net Loss Of CHF 21 Million
Brief: BB BIOTECH Q1 Net Income CHF -21 Million
Brief: BB Biotech Says All Proposals Of Board Of Directors Approved At AGM